Effect of the HafifMod Programme on Interdialytic Weight Gain in Hemodialysis Patients
End-Stage Renal Disease, Hemodialysis, Interdialytic Weight Gain
About this trial
This is an interventional prevention trial for End-Stage Renal Disease focused on measuring Hemodialysis patients, Fluid control, Salt control, Interdialytic weight
Eligibility Criteria
Inclusion Criteria: Those who gained more than 3% of their dry weight in at least one of the interdialytic weight gains covering the four-week period before the start of the study, Those who have received routine HD treatment for at least three months, Those whose dry weight has been determined, Smartphone users, Those who do not have severe visual and hearing impairment that would constitute an obstacle to the research, Those who are place, time and person oriented, Outpatients receiving HD treatment, Those with a routine HD program of 3 days and 4 hours a week, Those who do not have a psychiatric disorder that would constitute an obstacle to the research. Exclusion Criteria: Those receiving home hemodialysis treatment, Those in the home hemodialysis training process, Those with plans to make changes to the dialysis center in the next three months from the start of the study, Patients who do not undergo ultrafiltration because their urine volume is sufficient.
Sites / Locations
- Salih Güler
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Intervention Group or HafifMod Group
Control group
The HafifMod Programme; It consists of modular education practice and a mobile application offered to HD patients.
Prepared by a dietitian; As a result of the distribution of a printed material called "Nutrition Guide for Dialysis Patients" to the active control group, individuals will be informed about nutrition.